Uncategorized
STAT+: A new attack on AMA’s billing codes
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Brain Reid, who writes a newsletter on drug pricing policies, wrote “health care [sic]” in his Friday edition. I feel like a huge dork for laughing at that “sic” notation. Share your thoughts on the AP’s new compound noun dictum here, and send news tips to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.
CPT codes are the new front in fraud allegations
House oversight committee Chair James Comer (R-Ky.) is taking aim at the American Medical Association, linking the biggest doctor lobby’s billing codes to potential fraud, waste, and abuse.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Brain Reid, who writes a newsletter on drug pricing policies, wrote “health care [sic]” in his Friday edition. I feel like a huge dork for laughing at that “sic” notation. Share your thoughts on the AP’s new compound noun dictum here, and send news tips to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.
CPT codes are the new front in fraud allegations
House oversight committee Chair James Comer (R-Ky.) is taking aim at the American Medical Association, linking the biggest doctor lobby’s billing codes to potential fraud, waste, and abuse.
The most candid man in pharma strikes again.
When asked on Tuesday’s earnings call whether Pfizer would consider a “transformative M&A” deal in the near or medium term, CEO Albert Bourla said it wouldn’t.
“We …
Uncategorized
STAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing
The pharmaceutical industry saw its reputation among patient groups inch up last year, but the rise masks fresh concerns about the extent to which some companies are sufficiently focusing on patient needs, according to a new survey.
Of more than 2,400 groups queried, 57% reported that drugmakers had an “excellent” or “good” reputation as they went about the business of developing and providing medicines. That was up a notch from 56% in 2024 and back to the level seen the previous year. Even so, the results place the industry below the 60% rating in 2022.
The biggest factors contributing to the slight turnabout were patient centricity — which refers to prioritizing patient needs — and ensuring patient safety, according to PatientView, a research firm that canvassed patient groups from 35 countries between December 2025 and March 2026. The firm rated the reputation of 47 companies.
The pharmaceutical industry saw its reputation among patient groups inch up last year, but the rise masks fresh concerns about the extent to which some companies are sufficiently focusing on patient needs, according to a new survey.
Of more than 2,400 groups queried, 57% reported that drugmakers had an “excellent” or “good” reputation as they went about the business of developing and providing medicines. That was up a notch from 56% in 2024 and back to the level seen the previous year. Even so, the results place the industry below the 60% rating in 2022.
The biggest factors contributing to the slight turnabout were patient centricity — which refers to prioritizing patient needs — and ensuring patient safety, according to PatientView, a research firm that canvassed patient groups from 35 countries between December 2025 and March 2026. The firm rated the reputation of 47 companies.
BioNTech is making big cuts to its manufacturing footprint.
The German company said in its first-quarter earnings release that up to 1,860 manufacturing staff could be impacted by its planned downsizing …
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
Pfizer’s Albert Bourla says he has no mega-merger plans
STAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing
STAT+: A new attack on AMA’s billing codes
BioNTech to scale down manufacturing, over 1,800 jobs on the line
Viridian data lift prospects for thyroid eye disease drug
Pfizer is a 2029 story but Q126 lays foundation for growth
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Contributors9 years ago
The final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
The old and New Edition cast comes together to perform
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
Disney’s live-action Aladdin finally finds its stars